Cellebrite DI Ltd. Deferred Income Tax Expense (Benefit)
Cellebrite DI Ltd. (CLBT) reported Deferred Income Tax Expense (Benefit) of -$2.78 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-03-03
| Period end | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|
| 2025-12-31 | -$2.78M 20-F · filed 2026-03-03 | |
| 2025-06-30 | -$1.77M 6-K · filed 2025-08-14 | |
| 2024-12-31 | -$3.58M 20-F · filed 2026-03-03 | |
| 2024-06-30 | -$1.57M 6-K · filed 2025-08-14 | |
| 2023-12-31 | $5.40M 20-F · filed 2026-03-03 | |
| 2022-12-31 | -$2.39M 20-F · filed 2025-03-18 | |
| 2022-06-30 | -$1.84M 6-K · filed 2022-09-13 | |
| 2021-12-31 | -$1.64M 20-F · filed 2024-03-21 | |
| 2021-06-30 | -$569.00K 6-K · filed 2022-09-13 | |
| 2020-12-31 | -$2.82M 20-F · filed 2023-04-27 | |
| 2019-12-31 | -$1.67M 20-F · filed 2022-03-29 |